University of Campinas
Also known as: Centro Medico Campinas | Clinical Oncology Department, State University of Campinas (UNICAMP) | Department of Ophthalmology, University of Campinas | Faculty of Medical Sciences, State University of Campinas | FCM-CG | Francisco Groppo | Instituto de Nefrologia de Campinas | Luis Bahamondes | Osias Francisco de Souza | Piracicaba Dental School, University of Campinas | School of Dentistry of Piracicaba, State University of Campinas | STATE UNIVERSITY CAMPINAS | State University of Campinas | State University of Campinas, Campinas, Brazil | University of Campinas | University of Campinas, Brazil | University of Campinas (UNICAMP) | University of Campinas, UNICAMP
Highest phase reached
Phase 4
First clinical trial
Mar 1, 2003Last known activity
Aug 1, 2024
Timeline
1960s
- Jan 1, 1962
University of Campinas— Founded
Drugs by trial phase (103 distinct, 98 trials)
Phase 4 (41 own, 0 via acquisition)
Phase 3 (17 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Other trials (18 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Aggression
- Aggressive Periodontitis
- Albuminuria
- Anemia, Sickle Cell
- Anxiety Disorders
- beta-Thalassemia
- Carcinoma, Squamous Cell
- Cardiomegaly
- Carotid Artery Diseases
- Cataract
- Chronic Periodontitis
- Colorectal Neoplasms
- Conjunctivitis
- Conjunctivitis, Viral
- Constipation
- Coronary Artery Disease
- Coronary Disease
- Dental Caries
- Diabetes Complications
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Dry Eye Syndromes
- Dyslipidemias
- Eclampsia
- Endometriosis
- Endophthalmitis
- Esotropia
- Exotropia
- Fluoride Poisoning
- Fluorosis, Dental
- Head and Neck Neoplasms
- HELLP Syndrome
- Hemophilia A
- Hemophilia B
- Hemorrhage
- Hypersensitivity
- Hypertension
- Hypertrophy
- Hypoalphalipoproteinemias
- Infarction
- Insulin Resistance
- Iron Overload
- Kidney Diseases
- Kidney Failure, Chronic
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Macular Degeneration
- Macular Edema
- Menorrhagia
- Multiple Myeloma
- Myelodysplastic Syndromes
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasms
- Neoplasms, Plasma Cell
- Obesity
- Osteoarthritis
- Periodontal Diseases
- Periodontitis
- Postoperative Pain
- Pre-Eclampsia
- Preleukemia
- Pulpitis
- Rectal Neoplasms
- Recurrence
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Strabismus
- Syndrome
- Thalassemia
- Thinness
- Tooth, Impacted
- Toxoplasmosis
- Toxoplasmosis, Ocular
- Uveitis
- Uveitis, Anterior
- Vulvodynia
- Wounds and Injuries
Recent trials (50)
- NCT06601101Lead sponsorPhase 3Aug 1, 2024
- NCT06601101Sponsor investigatorPhase 3Aug 1, 2024
- NCT06711185OfficialPhase 3Jan 30, 2024
- NCT06711185Lead sponsorPhase 3Jan 30, 2024
- NCT06711185Sponsor investigatorPhase 3Jan 30, 2024
- NCT06465056CollaboratorPhase 2Jan 1, 2024
- NCT05775380Overall official - principal investigatorPhase 4Jun 15, 2023
- NCT05775380Reponsible party - principal investigatorPhase 4Jun 15, 2023
- NCT05775380Lead sponsorPhase 4Jun 15, 2023
- NCT05685394Reponsible party - principal investigatorPhase 4Jan 24, 2023
- NCT05685394Lead sponsorPhase 4Jan 24, 2023
- NCT05365321Lead sponsorPhase 1/Phase 2Dec 31, 2022
- NCT05365321Sponsor investigatorPhase 1/Phase 2Dec 31, 2022
- NCT05343078Lead sponsorPhase 4Apr 25, 2022
- NCT05343078Reponsible party - principal investigatorPhase 4Apr 25, 2022
Details
- Founded
- Campinas, São Paulo, BR Jan 1, 1962
- Last known activity
- Aug 1, 2024